General - Press Releases

Date	Title	Company
11-Jul-2023	Kindeva Drug Delivery, Chiesi Group, and H&T Presspart Announce Strategic Partnership for Dose Counter Technology Production	Businesswire
11-Jul-2023	First U.S. Patients Implanted with Innovative FIRE1 Remote Heart Failure Monitoring System in Early Feasibility Study	Businesswire
11-Jul-2023	Rallybio Announces Acceptance of Abstract for RLYB116 at the 29th International Complement Workshop (ICW)	Businesswire
11-Jul-2023	MEI Pharma Provides Final Reminder to Shareholders to Vote Today FOR the Merger With Infinity Pharmaceuticals	Businesswire
11-Jul-2023	MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer	Businesswire
11-Jul-2023	IconOVir Bio Announces First Patient Dosed in Phase 1 Clinical Trial of its Lead Product Candidate, ICVB-1042	Businesswire
11-Jul-2023	Skyelarke furthers its mission to break down barriers to clinical trial participation, with new SkyePay enhancements	Skyelarke
11-Jul-2023	Verastem Oncology Announces Promotion of Dan Paterson to Chief Executive Officer	Businesswire
11-Jul-2023	Septerna Secures $150 Million in Series B Financing to Advance Pipeline of Novel GPCR-targeted Medicines	Businesswire
11-Jul-2023	Silence Therapeutics Achieves $4 Million in Research Milestone Payments from Hansoh Pharma Collaboration	Businesswire
11-Jul-2023	Clinisupplies Acquires Great Bear Healthcare to Expand Direct-to-patient Chronic Care Services in the Community	Businesswire
11-Jul-2023	Opdivo (nivolumab) in Combination with Cisplatin-Based Chemotherapy Shows Overall Survival and Progression-Free Survival Benefit for Cisplatin-Eligible Patients with Unresectable or Metastatic Urothelial Carcinoma in the Phase 3 CheckMate -901 Trial	Businesswire
11-Jul-2023	Phastar's B Corp™ certification affirms its status as a 'force for good' organization	Phastar
11-Jul-2023	Global Mycoplasma Testing Market Report 2023: Sector is Expected to Reach $2.26 Billion by 2030 at a CAGR of 13.4% - ResearchAndMarkets.com	Businesswire
11-Jul-2023	Plastic Labware Industry Report and Forecast, 2023-2028: CAGR of 12.20% is Projected Despite Stringent Regulations and Increasingly Environmentally-Conscious Customers - ResearchAndMarkets.com	Businesswire
11-Jul-2023	NeuroSolv Therapeutics Developing Spinal Cord Injury Therapy, Seeks Clinical Trial Investment	Businesswire
11-Jul-2023	Gb Sciences' First-in-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study at the University of Lethbridge	Newswire
11-Jul-2023	NeuroSolv Therapeutics Developing New Therapy to Treat Spinal Cord Injury, Partners With AscellaHealth to Bring Therapy to Market	Businesswire
11-Jul-2023	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Jul-2023	TheraVet provides an update on its 2023 half-year development and portfolio strategy	Businesswire